Cigna Corporation

🇺🇸New York Stock Exchange
Back to all articles
Cigna Corporation stock analysis CI overview
Bullish +75

ROUNDUP: Cigna Group Lifts FY26 Adj. Profit View After Q1 Results Rise

📈 Cigna Group raised its full fiscal 2026 outlook for adjusted income from operations to at least $30.35 per share.

📊 This represents an increase from the previous guidance of $30.25 per share, driven by growth across its diverse business portfolio.

💰 First quarter net income rose to $1.65 billion or $6.26 per share compared to $1.32 billion or $4.85 per share last year.

🏥 Adjusted income from operations for the first quarter increased by 12% year-over-year to $2.06 billion or $7.79 per share.

📉 The growth in adjusted income was primarily fueled by higher contributions from Cigna Healthcare and Evernorth Health Services.

💵 Total revenue climbed 4.6% to $68.494 billion, mainly driven by expansion in the Evernorth Health Services unit.

👥 The company reported a total of 185.47 million customer relationships as of March 31, 2026, up from 182.21 million last year.

🏢 Total medical customers grew to 18.33 million, though pharmacy customers decreased to 121.02 million during the period.

⚠️ The earnings release mentioned plans to exit its individual exchange business by the end of the year while undertaking a strategic review of eviCore.

📉 Shares traded slightly lower in pre-market activity at $290.00, down 0.85 percent despite the positive earnings report.

🏦 Analyst firms including Cantor Fitzgerald and Mizuho recently raised their price targets for Cigna following the Q1 results.

🔝 Evernorth Health Services was specifically highlighted as a primary driver of both revenue and operational growth in the first quarter.

Bullish Signals
  • Cigna Group raised its fiscal 2026 adjusted income from operations outlook to at least $30.35 per share, up from the previous expectation of $30.25 per share.
  • First quarter shareholders' net income surged to $1.65 billion, or $6.26 per share, representing significant year-over-year growth driven by strong performance across the enterprise.
  • Adjusted income from operations for the first quarter increased by 12% to $7.79 per share compared to the same period last year.
  • Total revenue grew 4.6% year-over-year to $68.494 billion, primarily driven by expansion in the Evernorth Health Services unit.
  • The company's diversified portfolio of businesses continues to drive growth across its segments, reinforcing confidence in future profitability.
  • Analyst sentiment remains positive with Mizuho raising its Cigna stock price target to $330 following the Q1 results and strategic outlook.
Risk Factors
  • In pre-market activity, Cigna shares were trading at $290.00, down 0.85 percent from the previous session.
  • The company announced plans to exit its individual exchange business by the end of the year, signaling a contraction in that specific segment.
Full Analysis
Cigna Group (CI) reported stronger than expected financial results for the first quarter of fiscal 2026, leading management to raise its full-year fiscal 2026 adjusted profit outlook. The healthcare giant now expects adjusted income from operations to be at least $30.35 per share for FY2026, up from a previous expectation of $30.25 per share or $7.95 billion. This positive adjustment reflects growth across its diversified portfolio, specifically driven by contributions from Cigna Healthcare and Evernorth Health Services, which saw a 12 percent year-over-year increase in adjusted income from operations. For the first quarter itself, Cigna's net income reached $1.65 billion or $6.26 per share, compared to $1.32 billion or $4.85 per share the prior year. Revenue performance also exceeded expectations as fiscal 2026 total revenue rose 4.6 percent to $68.494 billion from $65.502 billion in the same quarter last year. This growth was primarily fueled by gains in Evernorth Health Services, though it was partially offset by the impact of a recent HCSC transaction. Adjusted revenues were reported at $68.517 billion against $65.452 billion from the previous year. Customer demographics showed mixed trends as of March 31, 2026, with total customer relationships increasing to 185.47 million from 182.21 million the year before, and medical customers growing to 18.33 million, even as pharmacy customers declined to 121.02 million. Following the earnings release, market reaction included pre-market trading where shares moved to $290.00, down 0.85 percent. However, analyst sentiment remains largely positive; Cantor Fitzgerald raised its stock price target for Cigna based on specialty growth, and Mizuho increased its target to $330 in response to the Q1 results. Concurrently, Cigna announced plans to exit the individual health insurance exchange by the end of the year and initiated a strategic review of its ownership interest in eviCore. This earnings beat has been widely covered by Wall Street analysts who have upgraded their outlooks following the report.